Cholesterol Depletion‐Enhanced Ferroptosis and Immunotherapy via Engineered Nanozyme
Cholesterol Depletion‐Enhanced Ferroptosis and Immunotherapy via Engineered Nanozyme
About this item
Full title
Author / Creator
Publisher
Germany: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
Germany: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Ferroptosis, an iron‐ and reactive oxygen species (ROS)‐dependent cell death, holds significant promise for tumor therapy due to its ability to induce lipid peroxidation (LPO) and trigger antitumor immune responses. However, elevated cholesterol levels in cancer cells impede ferroptosis and compromise immune function. Here, a novel nanozyme, Fe‐MOF...
Alternative Titles
Full title
Cholesterol Depletion‐Enhanced Ferroptosis and Immunotherapy via Engineered Nanozyme
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_91c5c08a528a4d11bff54b04d944b831
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_91c5c08a528a4d11bff54b04d944b831
Other Identifiers
ISSN
2198-3844
E-ISSN
2198-3844
DOI
10.1002/advs.202405826
